Creative Biolabs, a prominent player in the field of mRNA technology and non-viral delivery systems, is set to host a technical webinar titled “Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery.” This event will focus on the intricate challenges of achieving precise delivery beyond the liver, particularly in developing lipid nanoparticles (LNPs) for gene therapy targeting lung cancer.
Addressing Delivery Challenges
As mRNA therapeutics transition from systemic applications to targeted oncology treatments, effective delivery remains a significant hurdle. The upcoming webinar will be presented by Dr. Simone Pinto Carneiro, a leading researcher at Ludwig-Maximilians-University (LMU) in Munich. With her extensive background of over 13 years in RNA-lipid nanoparticles, Dr. Carneiro will share her team’s advancements in addressing KRAS mutations through innovative inhalable delivery systems.
Insights into LNP Formulation
Dr. Carneiro’s presentation will explore the complexities of formulating and characterizing lipid nanoparticles. She emphasizes that optimizing LNPs is about more than just encapsulating the therapeutic agents; it involves leveraging the potential of CRISPR/Cas9-LNPs as non-invasive inhalable therapies aimed at treating lung tumors effectively.
To support the evolving needs of RNA research, Creative Biolabs has developed a comprehensive custom mRNA delivery vehicle service. This service incorporates a variety of delivery methods, extending beyond conventional lipids to include polymer-based, hybrid, and biomimetic carriers.
Diverse Delivery Mechanisms
The range of vehicles offered includes:
- Polymer-based Vectors: These are designed for chemical flexibility and controlled release.
- Hybrid Systems: These combine the structural integrity of polymeric cores with lipid shells to enhance cellular entry.
-
Enveloped Virus-Like Particles (eVLPs): These exploit viral properties to facilitate penetration into hard-to-transfect cell types without the risks associated with replication-competent viruses.
Technical Insights for Successful Delivery
Transitioning from research and development to successful preclinical applications necessitates meticulous attention to several critical parameters:
- Vehicle Selection: While lipid nanoparticles currently represent the gold standard, custom eVLPs may offer enhanced T-cell activation in cancer vaccine applications. For targeted delivery to dendritic cells (DCs), mannose-functionalized LNPs are frequently utilized.
-
Stability and Scaling: Ensuring stability involves precise PEGylation techniques and careful adjustments of Zeta Potential and Polydispersity Index (PDI) to comply with stringent Chemistry, Manufacturing, and Controls (CMC) requirements.
-
Payload Versatility: Specialized hybrid vectors are increasingly in demand to effectively condense large-scale self-amplifying RNA (saRNA), ensuring robust protection and sustained expression from lower initial dosages.
Webinar Details
Title: Optimization of Lipid Nanoparticles for CRISPR/Cas9 Delivery
Lead Speaker: Dr. Simone Pinto Carneiro, Ph.D.
Registration: Attendees can find the latest schedule and register for the event through the official Creative Biolabs event page.
Creative Biolabs continues to establish itself as a leader in mRNA technology, providing an extensive array of solutions from high-purity synthesis to advanced vehicle formulation. To promote global scientific collaboration, the company regularly invites esteemed researchers to present their latest findings in complimentary technical sessions.
Conclusion
The webinar promises to be an enlightening opportunity for researchers and professionals interested in the cutting-edge developments of LNPs for CRISPR/Cas9 applications in lung cancer therapy. By focusing on innovative delivery mechanisms and addressing key technical challenges, Creative Biolabs is paving the way for future breakthroughs in gene therapy.
- Key Takeaways:
- The importance of precise delivery mechanisms for effective mRNA therapeutics.
- The role of Dr. Simone Pinto Carneiro and her research team in advancing LNP technology.
- The comprehensive services offered by Creative Biolabs for mRNA delivery solutions.
Read more → news.marketersmedia.com